Back to results
US 2020/0345872 A1Published application
Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsMarcus Kelly, Dangshe Ma, William Olson, Gavin Thurston
Life of this patent
Estimating the term…
Abstract
Radiolabeled anti-PD-L1 antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of PD-L1 proteins in a patient or sample.
Claims23
-10. (canceled)
A method for treating a tumor comprising:
- (a) selecting a subject with a solid tumor;
- (b) determining that the solid tumor is PD-L1-positive;
- and
- (c) administering one or more doses of an inhibitor of the PD-1/PD-L1 signaling axis to the subject in need thereof.
1 more element
(canceled)
Dependencies are inferred from the claim text.